Integrating immunizations into practice

Obstetrics and Gynecology

Volumn 121, Issue 4, 2013, Pages 897-903

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA VACCINE; INFLUENZA VACCINE; PERTUSSIS VACCINE; TETANUS TOXOID; WART VIRUS VACCINE;

DIPHTHERIA; DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED PRACTICE; HEALTH CARE PRACTICE; HUMAN; IMMUNIZATION; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; MATERNAL WELFARE; PERTUSSIS; PREGNANT WOMAN; PRIORITY JOURNAL; REVIEW; TETANUS;

EID: 84876234591     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/01.AOG.0000428788.74725.90     Document Type: Review

References (33)

1. Power ML, Leddy MA, Anderson BL, Gall SA, Gonik B, Schulkin J. Obstetrician-gynecologists> practices and perceived knowledge regarding immunization. Am J Prev Med 2009; 37: 231-4.
2. Influenza vaccination coverage among pregnant women: 2011-12 influenza season, United States. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep 2012; 61: 758-63.
3. Hoppe KK, Eckert LO. Achieving high coverage of H1N1 influenza vaccine in an ethnically diverse obstetric population: success of a multifaceted approach. Infect Dis Obstet Gynecol 2011; 2011: 746214.
4. Broughton DE, Beigi RH, Switzer GE, Raker CA, Anderson BL. Obstetric health care workers' attitudes and beliefs regarding influenza vaccination in pregnancy. Obstet Gynecol 2009; 114: 981-7.
5. Health Resources and Services Administration. What you need to know about the National Vaccine Injury Compensation Program (VICP). Rockville (MD): HRSA; 2011. Available at: http://www.hrsa.gov/vaccinecompensation/84521booklet.pdf. Retrieved November 30, 2012.
6. Leddy MA, Anderson BL, Gall S, Schulkin J. Obstetrician-gynecologists and the HPV vaccine: practice patterns, beliefs, and knowledge. J Pediatr Adolesc Gynecol 2009; 22: 239-46.
7. Kroger AT, Atkinson WL, Marcuse EK, Pickering LK. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). Advisory Committee on Immunization Practices (ACIP); Centers for Disease Control and Prevention (CDC) [published errata appear in MMWR Morb Mortal Wkly Rep 2007; 56: 256; MMWR Morb Mortal Wkly Rep 2006; 55: 1303; Pediatrics 2007; 119: 1008]. MMWR Recomm Rep 2006; 55: 1-48.
8. Human papillomavirus vaccination. Committee Opinion No. 467. American College of Obstetricians and Gynecologists. Obstet Gynecol 2010; 116: 800-3.
9. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention (CDC) [published erratum appears in MMWR Morb Mortal Wkly Rep 2010; 59: 1184]. MMWR Morb Mortal Wkly Rep 2010; 59: 626-9.
10. Joura EA, Garland SM, Paavonen J, Ferris DG, Perez G, Ault KA, et al. Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data. FUTURE I and II Study Group. BMJ 2012; 344: e1401.
11. Donovan B, Franklin N, Guy R, Grulich AE, Regan DG, Ali H, et al. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data. Lancet Infect Dis 2011; 11: 39-44.
12. Brotherton JM, Fridman M, May CL, Chappell G, Saville AM, Gertig DM. Early effect of the HPV vaccination pro-gramme on cervical abnormalities in Victoria, Australia: an ecological study. Lancet 2011; 377: 2085-92.
13. National and state vaccination coverage among adolescents aged 13-17 years - United States, 2011. Centers for Disease Control and Prevention (CDC) [published erratum appears in MMWR Morb Mortal Wkly Rep 2012; 61: 844]. MMWR Morb Mortal Wkly Rep 2012; 61: 671-7.
14. Kharbanda EO, Stockwell MS, Fox HW, Andres R, Lara M, Rickert VI. Text message reminders to promote human papillomavirus vaccination. Vaccine 2011; 29: 2537-41.
15. Garland SM, Ault KA, Gall SA, Paavonen J, Sings HL, Ciprero KL, et al. Pregnancy and infant outcomes in the clinical trials of a human papillomavirus type 6/11/16/18 vaccine: a combined analysis of five randomized controlled trials. Quadrivalent Human Papillomavirus Vaccine Phase III Investigators. Obstet Gynecol 2009; 114: 1179-88.
16. American Academy of Pediatrics, American College of Obstetricians and Gynecologists. Guidelines for perinatal care. 7th ed. Elk Grove Village (IL): AAP; Washington, DC: American College of Obstetricians and Gynecologists; 2012.
17. Neuzil KM, Reed GW, Mitchel EF, Simonsen L, Griffin MR. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol 1998; 148: 1094-102.
18. Lindsay L, Jackson LA, Savitz DA, Weber DJ, Koch GG, Kong L, et al. Community influenza activity and risk of acute influenza-like illness episodes among healthy unvac-cinated pregnant and postpartum women. Am J Epidemiol 2006; 163: 838-48.
19. Influenza vaccination during pregnancy. Committee Opinion No. 468. American College of Obstetricians and Gynecologists. Obstet Gynecol 2010; 116: 1006-7.
20. Benowitz I, Esposito DB, Gracey KD, Shapiro ED, Vazquez M. Influenza vaccine given to pregnant women reduces hospitalization due to influenza in their infants. Clin Infect Dis 2010; 51: 1355-61.
21. Interim results: influenza A (H1N1) 2009 monovalent vaccination coverage - United States, October-December 2009. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep 2010; 59: 44-8.
22. Jamieson DJ, Honein MA, Rasmussen SA, Williams JL, Swerdlow DL, Biggerstaff MS, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Novel Influenza A (H1N1) Pregnancy Working Group. Lancet 2009; 374: 451-8.
23. Louie JK, Acosta M, Jamieson DJ, Honein MA. Severe 2009 H1N1 influenza in pregnant and postpartum women in California. California Pandemic (H1N1) Working Group. N Engl J Med 2010; 362: 27-35.
24. General recommendations on immunization - recommendations of the Advisory Committee on Immunization Practices (ACIP). National Center for Immunization and Respiratory Diseases [published erratum appears in MMWR Recomm Rep 2011; 60: 993]. MMWR Recomm Rep 2011; 60(RR-2): 1-64.
25. Puck JM, Glezen WP, Frank AL, Six HR. Protection of infants from infection with influenza A virus by transpla-centally acquired antibody. J Infect Dis 1980; 142: 844-9.
26. Reuman PD, Ayoub EM, Small PA. Effect of passive maternal antibody on influenza illness in children: a prospective study of influenza A in mother-infant pairs. Pediatr Infect Dis J 1987; 6: 398-403.
27. Zaman K, Roy E, Arifeen SE, Rahman M, Raqib R, Wilson E, et al. Effectiveness of maternal influenza immunization in mothers and infants [published erratum appears in N Engl J Med 2009; 360: 648]. N Engl J Med 2008; 359: 1555-64.
28. Eick AA, Uyeki TM, Klimov A, Hall H, Reid R, Santosham M, et al. Maternal influenza vaccination and effect on influenza virus infection in young infants. Arch Pediatr Adolesc Med 2011; 165: 104-11.
29. Bisgard KM, Pascual FB, Ehresmann KR, Miller CA, Cianfrini C, Jennings CE, et al. Infant pertussis: who was the source? Pediatr Infect Dis J 2004; 23: 985-9.
30. Murphy TV, Slade BA, Broder KR, Kretsinger K, Tiwari T, Joyce PM, et al. Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants: recommendations of the Advisory Committee on Immunization Practices (ACIP). Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC) [published erratum appears in MMWR Morb Mortal Wkly Rep 2008; 57: 723]. MMWR Recomm Rep 2008; 57(RR-4): 1-51.
31. Update on immunization and pregnancy: tetanus, diph-theria, and pertussis vaccination. Committee Opinion No. 521. American College of Obstetricians and Gynecologists. Obstet Gynecol 2012; 119: 690-1.
32. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months - Advisory Committee on Immunization Practices (ACIP), 2011. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep 2011; 60: 1424-6.
33. Centers for Disease Control and Prevention (CDC). Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women - Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep 2013; 62: 131-5.